International Society of Pharmacometrics Inc (EIN 883345160) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2023

Legal Domicile

Principal Officer

Dr Wei Gao

Phone

9083591184

Tax Period

2024-01-01 to 2024-12-31

International Society of Pharmacometrics Inc, founded in 2023, is a community nonprofit in the Education sector that reported $2.1M in total revenue in fiscal year 2024.

Mission

Our mission is to advance and promote pharmacometrics, drive scientific excellence and innovation for the development of safe and effective therapies contributing to the improvement of global health.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $285,080

Program Service Revenue $1,782,956

Investment Income $41,979

Other Revenue $0

TOTAL REVENUE $2,110,015

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $1,961,807

Other Expenses $2,210,672

TOTAL EXPENSES $2,210,672

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,110,015	$1,979,733	+0.1%
Expenses	$2,210,672	$1,624,002	+0.4%
Net Income	$-100,657	$355,731	-1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CJ Musante	Immediate Past President	2.00	Officer Director	$0	$0	$0
Vijay Ivaturi	President	2.00	Officer Director	$0	$0	$0
Kevin Dykstra	President-Elect	2.00	Officer Director	$0	$0	$0
Wei Gao	Treasurer	2.00	Officer Director	$0	$0	$0
So Miyoshi	Secretary	2.00	Officer Director	$0	$0	$0
Amparo de la Pena	Trustee	2.00	Director	$0	$0	$0
Anja Henningsson	Trustee	2.00	Director	$0	$0	$0
Bernd Meibohm	Trustee	2.00	Director	$0	$0	$0
Jeff Sachs	Trustee	2.00	Director	$0	$0	$0
Pavan Vaddady	Trustee	2.00	Director	$0	$0	$0
Hao Zhu	Trustee	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,110,015	$2,210,672	$2,285,960	$-100,657
2023	$1,979,733	$1,624,002	$2,249,832	$355,731

International Society of Pharmacometrics Inc